118 related articles for article (PubMed ID: 37366099)
1. [Prognostic value and mechanism of long non-coding RNA DLEU1 in osteosarcoma].
Zhang JJ; Yang P; Shang XQ
Zhongguo Gu Shang; 2023 Jun; 36(6):559-64. PubMed ID: 37366099
[TBL] [Abstract][Full Text] [Related]
2. [LncRNA LINC-PINT regulating proliferation and apoptosis of osteosarcoma cells by targeting miR-524-5p].
Yang H; Cao C; Wang LJ
Zhonghua Zhong Liu Za Zhi; 2020 Apr; 42(4):325-330. PubMed ID: 32375449
[No Abstract] [Full Text] [Related]
3. LncRNA NORAD targets miR-410-3p to regulate drug resistance sensitivity of osteosarcoma.
Xie X; Liu W; Duan Z; Li X; Zhang L; Yang G
Cell Mol Biol (Noisy-le-grand); 2020 Jun; 66(3):143-148. PubMed ID: 32538761
[TBL] [Abstract][Full Text] [Related]
4. LncRNA LINC00628 overexpression inhibits the growth and invasion through regulating PI3K/Akt signaling pathway in osteosarcoma.
He R; Wu JX; Zhang Y; Che H; Yang L
Eur Rev Med Pharmacol Sci; 2018 Sep; 22(18):5857-5866. PubMed ID: 30280767
[TBL] [Abstract][Full Text] [Related]
5. The role and clinical significance of long noncoding RNA zinc finger E-box-binding homeobox two antisense RNA 1 in promoting osteosarcoma cancer cell proliferation, inhibiting apoptosis and increasing migration by regulating miR-145.
Zhou Y; Feng D; Gu X; Gao A; Liu Y
Anticancer Drugs; 2021 Feb; 32(2):168-177. PubMed ID: 32826416
[TBL] [Abstract][Full Text] [Related]
6. Decreased expression of long non-coding RNA MEG3 acts as a potential predictor biomarker in progression and poor prognosis of osteosarcoma.
Tian ZZ; Guo XJ; Zhao YM; Fang Y
Int J Clin Exp Pathol; 2015; 8(11):15138-42. PubMed ID: 26823857
[TBL] [Abstract][Full Text] [Related]
7. LOXL1-AS1 predicts poor prognosis and promotes cell proliferation, migration, and invasion in osteosarcoma.
Chen S; Li W; Guo A
Biosci Rep; 2019 Apr; 39(4):. PubMed ID: 30944201
[TBL] [Abstract][Full Text] [Related]
8. Long noncoding RNA DLEU1 aggravates osteosarcoma carcinogenesis via regulating the miR-671-5p/DDX5 axis.
Chen X; Zhang C; Wang X
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3322-3328. PubMed ID: 31379208
[TBL] [Abstract][Full Text] [Related]
9. Biomarker potential of lncRNA GNAS-AS1 in osteosarcoma prognosis and effect on cellular function.
Mi Z; Dong Y; Wang Z; Ye P
J Orthop Surg Res; 2021 Jul; 16(1):470. PubMed ID: 34321018
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of lncRNA H19 inhibits migration and invasion of human osteosarcoma through the NF-κB pathway.
Zhao J; Ma ST
Mol Med Rep; 2018 May; 17(5):7388-7394. PubMed ID: 29568924
[TBL] [Abstract][Full Text] [Related]
11. The potential value of lncRNA-BC050642 in osteosarcoma origination and outcomes.
Yang Y; Fei M; Zhou X; Li Y; Jin D
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):1859-1866. PubMed ID: 31397185
[No Abstract] [Full Text] [Related]
12. LncRNA MATN1-AS1 for Prediction of Prognosis in Osteosarcoma Patients and Its Cellular Function.
Liu Y; Wang D; Ji Q; Yan J
Mol Biotechnol; 2022 Jan; 64(1):66-74. PubMed ID: 34542816
[TBL] [Abstract][Full Text] [Related]
13. High expression of long non-coding RNA XIST in osteosarcoma is associated with cell proliferation and poor prognosis.
Li GL; Wu YX; Li YM; Li J
Eur Rev Med Pharmacol Sci; 2017 Jun; 21(12):2829-2834. PubMed ID: 28682435
[TBL] [Abstract][Full Text] [Related]
14. LncRNA CCAT2 enhances cell proliferation via GSK3β/β-catenin signaling pathway in human osteosarcoma.
Ruan R; Zhao XL
Eur Rev Med Pharmacol Sci; 2018 May; 22(10):2978-2984. PubMed ID: 29863240
[TBL] [Abstract][Full Text] [Related]
15. Long noncoding RNA CRNDE functions as a diagnostic and prognostic biomarker in osteosarcoma, as well as promotes its progression via inhibition of miR-335-3p.
Yu Y; Wang L; Li Z; Zheng Y; Shi Z; Wang G
J Biochem Mol Toxicol; 2021 May; 35(5):e22734. PubMed ID: 33522065
[TBL] [Abstract][Full Text] [Related]
16. Upregulation of Serum lncRNA DLEU1 Predicts Progression of Premalignant Endometrial Lesion and Unfavorable Clinical Outcome of Endometrial Cancer.
Shan L; Zhao T; Wang Y
Technol Cancer Res Treat; 2020; 19():1533033820965589. PubMed ID: 33327893
[TBL] [Abstract][Full Text] [Related]
17. LncRNA SNHG20 is associated with clinical progression and enhances cell migration and invasion in osteosarcoma.
Zhang J; Ju C; Zhang W; Xie L
IUBMB Life; 2018 Nov; 70(11):1115-1121. PubMed ID: 30120876
[TBL] [Abstract][Full Text] [Related]
18. LncRNA DLEU1/microRNA-300/RAB22A axis regulates migration and invasion of breast cancer cells.
Wang C; Xie XX; Li WJ; Jiang DQ
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10410-10421. PubMed ID: 31841195
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of long non-coding RNA DBH-AS1 inhibits osteosarcoma progression by PI3K-AKT signaling pathways and indicates good prognosis.
Liu ZB; Wang JA; Lv RQ
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1418-1427. PubMed ID: 30840262
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of long non-coding RNA HOST2 expression and its tumor-promotive function in human osteosarcoma.
Qi XD; Xu SY; Song Y
Eur Rev Med Pharmacol Sci; 2018 Feb; 22(4):921-927. PubMed ID: 29509239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
